Sakar Healthcare Ltd.
SAKAR Share PricePharmaceuticals & Drugs
₹394.95
-5.9 (-1.5%)
As on November 14, 2025
Exchange Scrips: BSENSESAKARISININE732S01012
Market Cap ₹ 870 Cr
P/E Ratio 49.53
Dividend Yield N/A
Performance
Market performance
Open399.05
High403.1
Volumes14,268
Prev394.95
Low391
As on2025-11-14
Historical performance
1 Year High411.8
3 Year High479
5 Year High479
1 Year Low210.1
3 Year Low185.55
5 Year Low72.25
Fundamentals
Company Valuation
Market Cap (₹Cr)
870
Face Value (₹)
10
P/E Ratio
49.53
Dividend Yield
N/A
Investment Returns
1 Year
28.3%
3 Years
73.9%
5 Years
393.4%
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 399.31 | Bearish |
| 10-DMA | 386.1 | Bullish |
| 20-DMA | 372.15 | Bullish |
| 50-DMA | 358.68 | Bullish |
| 100-DMA | 351.62 | Bullish |
| 200-DMA | 314.27 | Bullish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 4 | 4 | 4 | 4 | 4 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 4 | 4 | 4 | 4 | 4 |
| Public Investors | 7561 | 8111 | 8604 | 8594 | 7863 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 49.53.
- 3Y Stock Price CAGR of the stock is 19.2.
- The stock has a beta of 0.7.
- In the last financial year, the company had an EBITDA of ₹510 Million.
- The company generated revenue of ₹1776 Million in the previous financial year.
Sakar Healthcare Ltd.
394.95-5.9 (-1.5%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1356983.3
No. of Shares: 3436 (Approx)
Performance:35.7%
P/L: ₹356983.3
Top Gainers
Top Losers
| Symbol | Change% |
|---|---|
| TOLINS | 168.46(-10%) |
| FISCHER | 58.75(-10%) |
| WEALTH | 1051.8(-10%) |
| ATL | 31.49(-9%) |
| MASTERTR | 104.98(-8%) |
| THOMASCOTT | 418.7(-8%) |
| MALLCOM | 1270.2(-8%) |
| LAXMIINDIA | 137.12(-7%) |
Peer Comparison
Get Your Portfolio Reviewed
